Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Hyperforin induced activation of the Pregnane X Receptor is influenced by the Organic Anion Transporting Polypeptide 2B1 (OATP2B1)

Anima M. Schaefer, Olivier Potterat, Isabell Seibert, Orlando Fertig and Henriette E. Meyer zu Schwabedissen
Molecular Pharmacology December 20, 2018, mol.118.114066; DOI: https://doi.org/10.1124/mol.118.114066
Anima M. Schaefer
University of Basel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Potterat
University of Basel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabell Seibert
University of Basel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orlando Fertig
University of Basel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henriette E. Meyer zu Schwabedissen
University of Basel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Data Supplement

  • Supplemental Figures -

    Supplemental Figure 1 - Counterflow experiments performed in MDCKII cells

    Supplemental Figure 2 - Competitive counterflow experiment with hyperforin (A) or hypericin (B)

    Supplemental Figure 3 - Chromatograms of a mixture of the references hypericin (TOCRIS) and pseudohypericin (Sigma-Aldrich), and of the 11 in Switzerland marketed St. John’s wort formulations

    Supplemental Figure 4 - Chromatograms of the reference hyperforin (Sigma-Aldrich) and of the 11 in Switzerland marketed St. John’s wort formulations.

  View article

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics